XT
CGON icon

XTX Topco’s CG Oncology CGON Stock Holding History

XTX Topco’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$504K Buy
7,095
+1,736
+32% +$113K 0.01% 2447
2026
Q1 		$363K Sell
5,359
-28,351
-84% -$1.61M 0.01% 2315
2025
Q4 		$1.4M Buy
+33,710
New +$1.39M 0.04% 787
2025
Q1 		– Sell
-19,996
Closed -$573K – 2487
2024
Q4 		$573K Buy
+19,996
New +$684K 0.05% 654
2024
Q2 		– Sell
-5,728
Closed -$251K – 1930
2024
Q1 		$251K Buy
+5,728
New +$234K 0.03% 997

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's CGON Position: Q2 2026 in Review

XTX Topco increased its CG Oncology (CGON) stake by 32% in Q2 2026, buying an estimated $113K and bringing the position to 7,095 shares worth $504K. The position accounts for 0.01% of the portfolio, ranked #2447.

XTX Topco first reported a position in CGON in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.4M in Q4 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • XTX Topco held 7,095 shares of CG Oncology worth $504K as of Q2 2026.
  • XTX Topco bought 1,736 CG Oncology shares in Q2 2026, an estimated $113K.
  • CG Oncology made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2447 holding.
  • XTX Topco first reported a position in CG Oncology in Q1 2024 and has held it in 5 quarters since.
  • XTX Topco's CG Oncology position peaked at $1.4M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.